INTRODUCTION
============

Metabolic syndrome (Mets) is a multifactorial disease characterized by abdominal obesity, elevated glucose, and blood pressure, and altered lipid metabolism \[[@b1-phrp-08-130],[@b2-phrp-08-130]\]. Development of Mets is associated with increasing age and poor lifestyle, such as inadequate physical activity, smoking, alcohol drinking, and high-fat or high-calorie diets \[[@b3-phrp-08-130],[@b4-phrp-08-130]\]. Among Americans, the prevalence of Mets was 34.7% in 2011--2012 \[[@b5-phrp-08-130]\]. In particular, women and people aged 60 years or older had a higher prevalence of Mets than the overall prevalence \[[@b5-phrp-08-130]\]. Among Korean adults older than 19 years of age, the average prevalence of Mets was 18.8% in 2010, and the prevalence was higher among women and individuals older than 50 years of age \[[@b4-phrp-08-130]\]. The prevalence of Mets among the Korean population is expected to increase with an increasing number of older individuals and adoption of a Westernized lifestyle \[[@b4-phrp-08-130]\]. In a longitudinal study, Mets was identified as a major risk factor for cerebral-cardiovascular disease \[[@b6-phrp-08-130]\]. Thus, identification of risk factors is important to decrease the prevalence of morbidity and mortality from complications due to Mets in high-risk populations such as the elderly and women in Korea \[[@b4-phrp-08-130]\].

Depression is a significant predictor of type 2 diabetes mellitus (T2DM) and cardiovascular disease \[[@b7-phrp-08-130]--[@b9-phrp-08-130]\]. Depression is also considered to be significantly associated with Mets \[[@b10-phrp-08-130]\]. In previous studies, depression was observed as a critical risk factor for the development of Mets in middle-aged and older people \[[@b11-phrp-08-130],[@b12-phrp-08-130]\]. However, the effects of depression on Mets vary in accordance with ethnicity and sex. Depression was significantly associated with the development of Mets among American and European populations \[[@b13-phrp-08-130]\], but it was not a significant predictor of Mets among the Japanese population regardless of sex \[[@b14-phrp-08-130]\]. Allison et al \[[@b15-phrp-08-130]\] proposed that populations with different sociocultural backgrounds have different health risks due to genetic and socioeconomic heterogeneity. In particular, the difference in the level of psychological stress and social support, as well as lifestyle such as diet, may alter the prevalence of Mets among ethnic groups \[[@b16-phrp-08-130],[@b17-phrp-08-130]\]. In these contexts, the effects of depression on the development of Mets among the Korean population may be different from that among other ethnic groups. Toker et al \[[@b18-phrp-08-130]\] proposed that depression may be associated with Mets among women, but not among men. According to previous studies, depression is significantly associated with the development of Mets, and it worsens the severity of Mets among African-American women but not among men \[[@b10-phrp-08-130],[@b19-phrp-08-130],[@b20-phrp-08-130]\]. In a longitudinal study, depression may also be a significant predisposing factor for the development of Mets among Finnish women but not among men \[[@b21-phrp-08-130]\]. Owing to these findings, the significance of the effects of depression on the development of Mets may vary by sex. In this study, we aimed to identify the association between depression and the development of Mets among middle-aged and older Korean adults on the basis of sex.

MATERIALS AND METHODS
=====================

1. Study design and samples
---------------------------

We used a cross-sectional design for the secondary analysis of the 2010--2014 Korean National Health and Nutrition Examination Survey (NHANES). The NHANES is a nationwide survey that evaluates the health and nutritional status of the Korean population. In this survey, 41,102 people were selected by stratified sampling method. Samples for data analysis included adults older than 40 years of age who had completed a questionnaire that assessed health and nutritional status and undergone a physical examination. Finally, data from 4,342 adults (1,938 men and 2,404 women) were analyzed.

2. Measurements
---------------

### 1) Metabolic syndrome (Mets)

In this study, Mets was defined in accordance with the clinical diagnostic criteria developed by the American Heart Association and the National Heart, Lung, and Blood Institute \[[@b2-phrp-08-130]\]. For waist circumference, we used the criteria suggested by the Korean Society for the Study of Obesity \[[@b22-phrp-08-130]\].

The subjects were diagnosed with Mets when three or more of the following five components were present: waist circumference ≥ 90 cm in men and ≥ 85 cm in women; blood pressure ≥ 130/85 mmHg or use of medication for hypertension; high-density lipoprotein (HDL) cholesterol level \< 40 mg/dL in men and \< 50 mg/dL in women or use of medication for reduced HDL level; triglyceride (TG) level ≥ 150 mg/dL or use of medication for increased TG level; and fasting glucose level ≥ 100 mg/dL or use of medication for hyperglycemia.

### 2) Depression

Depression was assessed with the following question: "Do you currently have depression diagnosed by a psychiatrist?"

### 3) Covariates

To adjust for covariates related to the development of Mets, we assessed variables associated with the development of Mets such as biological factors (age, obesity, family history of hypertension, dyslipidemia, T2DM or cerebral-cardiovascular disease, and menopause \[for women\]), social factors (educational level, marital status, and family income), and individual health-related behavioral factors (smoking, heavy alcohol consumption, physical activity, and eating out). The covariates and their categories are presented in [Table 1](#t1-phrp-08-130){ref-type="table"}.

3. Statistical analysis
-----------------------

General characteristics of the samples, including depression, Mets, and covariates, were analyzed and shown as frequencies and percentages. The difference in the prevalence of depression and Mets by sex was analyzed using the chi-square test, which was also used to confirm significant covariates for the development of Mets based on sex. Significant covariates were incorporated into logistic regression to adjust the confounding effects of covariates. Logistic regression analysis was conducted on weighted data using a complex sample procedure to identify the association between depression and the development of Mets with or without adjustment for covariates. *p*-values of less than 0.05 were considered statistically significant. Analyses were performed using IBM SPSS Statistics software (version 22.0 for Windows; IBM Co., Armonk, NY, USA).

RESULTS
=======

1. Characteristics of samples regarding Mets, depression, and covariates related to the development of Mets
-----------------------------------------------------------------------------------------------------------

[Table 1](#t1-phrp-08-130){ref-type="table"} shows the prevalence of Mets and depression as well as the biological, social, and individual health-related behavioral factors related to the development of Mets. Among the samples, 4.1% of the men and 11.7% of the women had clinical depression. In addition, 37.0% of the men and 25.9% of the women had Mets. Most of the men and women (81.9% and 85.5%, respectively) were older than 40 years and younger than 65 years. Almost half of the men and women (52.4% and 56.7%, respectively) had a family history of hypertension, dyslipidemia, T2DM, and cerebral-cardiovascular disease. More than half of the men and women (65.2% and 55.9%, respectively) were obese. About one-third of the men and women (35.4% and 30.7%, respectively) took an antidepressant medication ([Table 1](#t1-phrp-08-130){ref-type="table"}).

2. Difference of prevalence of depression and Mets by sex
---------------------------------------------------------

Women had a higher prevalence of depression than did men (χ^2^ = 86.197, *p* \< 0.001). Men had a higher prevalence of Mets than did women (χ^2^ = 62.680, *p* \< 0.001). Regarding Mets components, men had higher blood pressure (χ^2^ = 88.277, *p* \< 0.001), TG (χ^2^ = 161.496, *p* \< 0.001), fasting blood glucose (χ^2^ = 150.872, *p* \< 0.001), and higher waist circumference (χ^2^ = 8.808, *p* = 0.012) than did women. However, women had lower HDL cholesterol than did men (χ^2^ = 71.956, *p* \< 0.001) ([Table 2](#t2-phrp-08-130){ref-type="table"}).

3. Association between depression and the development of Mets
-------------------------------------------------------------

Before covariate adjustment, depression was significantly associated with the development of Mets among women (odds ratio \[OR\], 1.586; 95% confidence interval \[CI\], 1.152--2.183; *p* = 0.005). Among women, depression was associated with higher blood pressure (OR, 1.462; 95% CI, 1.102--1.940; *p* = 0.008), waist circumference (OR, 1.865; 95% CI, 1.345--2.587; *p* \< 0.001), and higher TG (OR, 1.856; 95% CI, 1.366--2.522; *p* \< 0.001) than the specified criteria for Mets. Among men, depression was associated with higher TG (OR, 1.679; 95% CI, 1.001--2.818; *p* = 0.050) than that specified by the criteria for Mets ([Table 3](#t3-phrp-08-130){ref-type="table"}).

After covariate adjustment, depression was significantly associated with higher waist circumference (adjusted OR \[AOR\], 1.532; 95% CI, 1.046--2.245; *p* = 0.029) and higher TG among women (AOR, 1.511; 95% CI, 1.029--2.219; *p* = 0.035) than that specified by the criteria for Mets. Among men, depression was not significantly associated with the development of Mets ([Table 4](#t4-phrp-08-130){ref-type="table"}).

DISCUSSION
==========

This study identified a sex-specific association between depression and the development of Mets among Korean population older than 40 years of age. Almost one-third of the Korean adults older than 40 years of age had Mets. According to the Korean NHANES for 1998--2007, the prevalence of Mets among Korean adults over 20 years of age was 24.9% in 1998, 31.3% in 2007, and 21.7% in 2012 after age adjustment \[[@b23-phrp-08-130],[@b24-phrp-08-130]\]. Specifically, the prevalence of Mets was over 50% after the age of 50 years in both men and women in 2007 and 2012 \[[@b23-phrp-08-130],[@b24-phrp-08-130]\]. When the age-adjusted prevalence of Mets in the United States was 34.2% in 2006 \[[@b25-phrp-08-130]\], the Korean population showed almost a similar risk for the development of Mets. Thus, an active identification of risk factors for the development of Mets and early intervention are required to prevent Mets-related complication.

In this study, with unadjusted covariates, depression was significantly associated with the development of Mets, and most of the Mets components were among women. Among men, depression was associated with TG level only. After covariate adjustment, depression was associated with higher waist circumference and higher TG level among women. However, depression was not associated with the development of Mets among men. In a prospective cohort study among Dutch population, depression was considerably associated with higher waist circumference and TG level during a 6-year follow-up \[[@b13-phrp-08-130]\]. In particular, Toker et al \[[@b18-phrp-08-130]\] proposed that depression may be positively associated with higher waist circumference and TG level among women. Similarly, depressive symptoms are associated with higher risk for abdominal obesity among women, but not among men, after controlling the covariates \[[@b19-phrp-08-130],[@b26-phrp-08-130]\]. Among German population, depressive symptoms are significantly associated with higher waist circumference and dyslipidemia (lower HDL cholesterol) among women, but not among men, after covariate adjustment \[[@b27-phrp-08-130]\]. Depressive symptoms also exhibit effects on visceral adiposity in middle-aged American women, but not in men \[[@b28-phrp-08-130]\]. Thus, depression was considered to have more detrimental effects on the development of Mets among women than among men \[[@b29-phrp-08-130]\].

Schulz et al \[[@b30-phrp-08-130]\] reported that women show higher increased cortisol level than men in chronic stress. In the same vein, depressive symptoms significantly affect cortisol secretion among women, but not among men \[[@b31-phrp-08-130],[@b32-phrp-08-130]\]. Furthermore, an elevated cortisol level may be considered a mediator between depression and Mets components among women \[[@b24-phrp-08-130]\]. In these contexts, depressive symptoms negatively affect Mets components such as higher waist circumference, higher blood pressure, and blood, and lower HDL cholesterol after covariate adjustment among women \[[@b27-phrp-08-130]\]. Björntorp \[[@b33-phrp-08-130]\] proposed that cortisol binds to glucocorticoid receptors with a high density in the visceral fat deposit. This activity enhances lipoprotein lipase and inhibits lipid mobilization, which results in increased visceral fat. These effects are more elevated with low levels of sex steroid hormone \[[@b33-phrp-08-130]\], which tends to be low in depression \[[@b34-phrp-08-130]\]. Thus, low levels of sex steroids may show a more evident effect on the accumulation of visceral fat among depressed women than among men \[[@b27-phrp-08-130]\]. In particular, older age may be associated with an increase in the stress response and cortisol level more often among women than among men \[[@b35-phrp-08-130]\]. Thus, middle-aged and older women with depression may be more vulnerable to Mets development than are men.

In conclusion, depression was an associated factor for the development of Mets among middle-aged and older Korean women. In the present and in a previous study \[[@b36-phrp-08-130]\], Korean women tended to have a higher prevalence of depression than did men. Thus, screening and early management of depression are essential to prevent Mets and reduce the severity of Mets. In particular, health care providers in communities should focus on the association between depression and Mets in women with depressive symptoms and evaluate Mets components. Furthermore, interventions for relieving the depressive symptoms should be provided for women at risk for Mets.

Our study had several limitations. First, we did not control each covariate owing to the limitation of the secondary data analysis. Original studies that control covariates are suggested to confirm the association between depression and the development of Mets among Korean population. Second, our study focused only on the sex-specific association between depression and Mets. However, the association between depression and Mets may be different by other socio-demographic factors (e.g., age, residence, and socioeconomic level). Thus, further examinations based on various socio-demographic factors are required. Finally, we did not explain the specificity of the development of Mets in Korean population in this study. Multi-ethnic studies, including the Korean population, are recommended to verify the association between depression and Mets with genetic and sociocultural factors on the basis of ethnicity.
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###### 

Characteristics of samples regarding metabolic syndrome (Mets), depression, and covariates related to the development of Mets

  Variable                                                                Men (n = 1,938)               Women (n = 2,404)   
  ----------------------------------------------------------------------- ----------------------------- ------------------- --------------
  Independent variable                                                                                                      
   Depression                                                             Yes                           88 (4.1)            312 (11.7)
                                                                          No                            1,850 (95.9)        2,092 (88.3)
  Dependent variable                                                                                                        
   Metabolic syndrome                                                     Yes                           704 (37.0)          704 (25.9)
                                                                          No                            1,234 (63.0)        1,700 (74.1)
   Blood pressure                                                         Yes                           1,035 (51.0)        972 (36.9)
                                                                          No                            903 (49.0)          1,432 (63.1)
   Waist circumference                                                    Yes                           525 (27.2)          610 (23.3)
                                                                          No                            1,413 (72.8)        1,794 (76.7)
   High density lipoprotein                                               Yes                           500 (26.2)          970 (38.3)
                                                                          No                            1,438 (73.8)        1,434 (61.7)
   Triglyceride                                                           Yes                           875 (49.0)          791 (30.1)
                                                                          No                            1,063 (51.0)        1,613 (69.9)
   Fasting blood glucose                                                  Yes                           931 (48.1)          744 (29.9)
                                                                          No                            1,007 (51.9)        1,660 (70.1)
  Covariates                                                                                                                
   Biological factors                                                                                                       
    Age (y)                                                               40--64                        1,338 (81.9)        1,915 (85.5)
                                                                          ≥ 65                          600 (18.1)          489 (14.5)
    Obesity                                                               Non-obesity                   722 (34.8)          1,014 (44.1)
                                                                          obesity                       1,216 (65.2)        1,390 (55.9)
    Family history                                                        Yes                           921 (52.4)          1,310 (56.7)
                                                                          No                            1,017 (47.6)        1,094 (43.3)
    Menopause                                                             Yes                           \-                  1,504 (56.2)
                                                                          No                            \-                  900 (43.8)
   Social factors                                                                                                           
    Education level                                                       Below elementary school       407 (16.5)          769 (27.6)
                                                                          Middle school                 298 (14.2)          340 (13.7)
                                                                          High school                   633 (35.9)          842 (38.0)
                                                                          Above college                 600 (33.4)          453 (20.7)
    Marital status                                                        Married                       1,871 (95.5)        2,369 (98.6)
                                                                          Single                        67 (4.5)            35 (1.4)
    Family income                                                         Low                           355 (13.9)          455 (16.7)
                                                                          Mid                           999 (53.8)          1,269 (53.1)
                                                                          High                          584 (32.3)          680 (30.2)
  Individual health-related behavioral factors                                                                              
   Smoking                                                                Never smoked                  291 (14.9)          2,176 (89.8)
                                                                          At the past, not in current   880 (41.4)          96 (4.3)
                                                                          Occasionally in current       76 (4.3)            32 (1.5)
                                                                          Daily in current              691 (39.4)          100 (4.4)
   Heavy alcohol consumption                                              Yes                           483 (29.6)          80 (3.6)
                                                                          No                            1,455 (70.4)        2,324 (96.4)
   Physical activity                                                      Yes                           563 (29.4)          709 (29.4)
                                                                          No                            1,375 (70.6)        1,695 (70.6)
   Eating out                                                             \> 1 times/day                615 (36.7)          240 (10.6)
                                                                          1--6 times/week               810 (41.8)          1,188 (50.7)
                                                                          1--3 times/month              371 (16.2)          736 (29.9)
                                                                          \< 1 times/month              142 (5.3)           240 (8.8)
   Antidepressant medication[a](#tfn2-phrp-08-130){ref-type="table-fn"}   Yes                           30 (35.4)           102 (30.7)
                                                                          No                            58 (64.6)           210 (69.3)

Values are presented as underweighted number (weighted percentage).

Men=88, women=312.

###### 

Sex-based difference in prevalence of depression and metabolic syndrome (component)

  Outcome variable            Category   Men (n = 1,938)   Women (n = 2,404)   χ^2^      *p*-value
  --------------------------- ---------- ----------------- ------------------- --------- -----------
  Metabolic syndrome          Yes        704 (37.0)        704 (25.9)          62.680    \< 0.001
                              No         1,234 (63.0)      1,700 (74.1)                  
   Blood pressure             Yes        1,035 (51.0)      972 (36.9)          88.277    \< 0.001
                              No         903 (49.0)        1,432 (63.1)                  
   Waist circumference        Yes        525 (27.2)        610 (23.3)          8.808     0.012
                              No         1,413 (72.8)      1,794 (76.7)                  
   High density lipoprotein   Yes        500 (26.2)        970 (38.3)          71.956    \< 0.001
                              No         1,438 (73.8)      1,434 (61.7)                  
   Triglyceride               Yes        875 (49.0)        791 (30.1)          161.496   \< 0.001
                              No         1,063 (51.0)      1,613 (69.9)                  
   Fasting blood glucose      Yes        931 (48.1)        744 (29.9)          150.872   \< 0.001
                              No         1,007 (51.9)      1,660 (70.1)                  
  Depression                  Yes        88 (4.1)          312 (11.7)          86.197    \< 0.001
                              No         1,850 (95.9)      2,092 (88.3)                  

Values are presented as underweighted number (weighted percentage).

###### 

Sex-based association between depression and the development of metabolic syndrome (component) before covariate adjustment

  Outcome variable                      Depression                                                         
  ------------------------------------- ------------ ------- -------------- ------- ------- -------------- ----------
  Metabolic syndrome (Ref. No)          Yes          1.162   0.653--2.068   0.608   1.586   1.152--2.183   0.005
                                                                                                           
   Blood pressure (Ref. No)             Yes          1.166   0.674--2.018   0.581   1.462   1.102--1.940   0.008
                                                                                                           
   Waist circumference (Ref. No)        Yes          1.008   0.546--1.862   0.979   1.865   1.345--2.587   \< 0.001
                                                                                                           
   High density lipoprotein (Ref. No)   Yes          0.929   0.498--1.731   0.815   1.283   0.955--1.726   0.098
                                                                                                           
   Triglyceride (Ref. No)               Yes          1.679   1.001--2.818   0.050   1.856   1.366--2.522   \< 0.001
                                                                                                           
   Fasting blood glucose (Ref. No)      Yes          0.906   0.521--1.574   0.725   1.260   0.923--1.720   0.145

OR, odds ratio; CI, confidence interval; Ref., reference.

###### 

Sex-based association between depression and the development of metabolic syndrome (component) after covariate adjustment

  Outcome variable                     Depression                                                               
  ------------------------------------ ------------ ---------- -------------- ------- ---------- -------------- -------
  Metabolic syndrome (Ref. No)         Yes          1.227^a^   0.660--2.280   0.517   1.253^g^   0.880--1.785   0.210
                                                                                                                
  Blood pressure (Ref. No)             Yes          1.186^b^   0.681--2.068   0.546   1.142^g^   0.835--1.562   0.407
                                                                                                                
  Waist circumference (Ref. No)        Yes          1.039^c^   0.512--2.105   0.916   1.532^h^   1.046--2.245   0.029
                                                                                                                
  High density lipoprotein (Ref. No)   Yes          0.923^d^   0.482--1.765   0.808   1.139^g^   0.843--1.540   0.395
                                                                                                                
  Triglyceride (Ref. No)               Yes          1.488^e^   0.779--2.840   0.228   1.511^h^   1.029--2.219   0.035
                                                                                                                
  Fasting blood glucose (Ref. No)      Yes          0.861^f^   0.483--1.533   0.610   1.061^g^   0.766--1.470   0.720

AOR, adjusted odds ratio; CI, confidence interval; Ref., reference.

Adjusted for ^a^smoking, heavy alcohol consumption, obesity; ^b^age, family income, smoking, heavy alcohol consumption, family history, obesity; ^c^heavy alcohol consumption, physical activity, obesity; ^d^education level, obesity; ^e^age, education level, smoking, heavy alcohol consumption, family history, eating out, obesity, antidepressant medication; ^f^education level, heavy alcohol consumption, obesity; ^g^age, education level, family income, eating out, obesity, menopause; ^h^education level, family income, heavy alcohol consumption, eating out, obesity, menopause, antidepressant medication.
